FBIO Fortress Biotech, Inc.

NASDAQ
$2.93

Fortress Biotech, Inc. (FBIO) is expected to report earnings on November 12, 2026, after the market close. The stock has had a Post-Earnings Announcement Drift (PEAD) of +0.3% since its last earnings release on August 13, 2026.

Fortress Biotech Reported Earnings
Thursday, August 13, 2026 · 4:05 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 12
Thursday · 4:10 PM ET
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $2.93

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Fortress Biotech, Inc.

Fortress Biotech, Inc. is a biopharmaceutical company. The company is engaged in acquiring, developing and commercializing novel pharmaceutical and biotechnology products. Fortress Biotech, Inc., formerly known as Coronado Biosciences, Inc., is based in NEW YORK, United States.

Sector

Healthcare

Industry

Biotechnology